ロード中...
Peptide Nanomedicines for Treatment of Acute Lung Injury
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) represent a heterogenous group of lung disease in critically ill patients. Despite the increased understanding of the molecular pathogenesis of ARDS, the mortality remains unacceptably high, ranging from 34% to 64%. Hence, ARDS r...
保存先:
| 出版年: | Methods Enzymol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Inc.
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7149708/ https://ncbi.nlm.nih.gov/pubmed/22449933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/B978-0-12-391860-4.00016-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|